Three-dimensional co-culture cancer model with vascular endothelial cell for anti-cancer drug testing

Three-dimensional co-culture cancer model with vascular endothelial cell for anti-cancer drug testing

Detalhes bibliográficos
Principais autores:	Wan, X, Cui, Z, Ye, H
Formato:	Journal article
Publicado em:	2012

Registros relacionados

Three-dimensional perfused tumour spheroid model for anti-cancer drug screening
por: Wan, X, et al.
Publicado em: (2016)

Development of advanced three-dimensional tumour models for anti-cancer drug testing
por: Wan, X
Publicado em: (2014)

Perfused three-dimensional organotypic culture of human cancer cells for therapeutic evaluation
por: Wan, X, et al.
Publicado em: (2017)

Data of a fluorescent imaging-based analysis of anti-cancer drug effects on three-dimensional cultures of breast cancer cells
por: Junji Itou, et al.
Publicado em: (2015-12-01)

The Effects of Anti-Vascular Endothelial Growth Factor Drugs on Retinal Pigment Epithelial Cell Culture
por: Mustafa Şahiner, et al.
Publicado em: (2018-08-01)

Morphological analysis of human umbilical vein endothelial cells co-cultured with ovarian cancer cells in 3D: an oncogenic angiogenesis assay
por: Wan, X, et al.
Publicado em: (2017)

Debate on the various anti-vascular endothelial growth factor drugs
por: Khalili Mohammad, et al.
Publicado em: (2008-01-01)

Mimicking Angiogenesis in vitro: Three-dimensional Co-culture of Vascular Endothelial Cells and Perivascular Cells in Collagen Type I Gels
por: Markus Auler, et al.
Publicado em: (2017-04-01)

Endothelial Progenitor Cells Promote Directional Three-Dimensional Endothelial Network Formation by Secreting Vascular Endothelial Growth Factor
por: Abe, Yoshinori, et al.
Publicado em: (2014)

Endothelial progenitor cells promote directional three-dimensional endothelial network formation by secreting vascular endothelial growth factor.
por: Yoshinori Abe, et al.
Publicado em: (2013-01-01)

Anti-vascular endothelial growth factor receptor in colorectal cancer: A review
por: Alfredo Colombo, et al.
Publicado em: (2023-07-01)

Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy
por: Tobiloba C. Elebiyo, et al.
Publicado em: (2022-01-01)

Anti-vascular endothelial growth factor drugs in polypoidal choroidal vasculopathy
por: Jay Kumar Chhablani
Publicado em: (2011-01-01)

Two-Dimensional and Spheroid-Based Three-Dimensional Cell Culture Systems: Implications for Drug Discovery in Cancer
por: Anali del Milagro Bernabe Garnique, et al.
Publicado em: (2024-06-01)

Addition of photodynamic therapy to anti-vascular endothelial growth factor drugs compared to anti-vascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy
por: Franco Manzur Yarur, et al.
Publicado em: (2021-09-01)

Development of a high-throughput three-dimensional invasion assay for anti-cancer drug discovery.
por: Nikki A Evensen, et al.
Publicado em: (2013-01-01)

A microfluidics platform for simultaneous evaluation of sensitivity and side effects of anti-cancer drugs using a three-dimensional culture method
por: Yuki Kobayashi, et al.
Publicado em: (2025-01-01)

Application of multiple parallel perfused microbioreactors and three-dimensional stem cell culture for toxicity testing.
por: Cui, Z, et al.
Publicado em: (2007)

Establishment of an Three-Dimensional Vascularized Micro-Tumor Model and Screening of Chemotherapeutic Drugs
por: Qian Ye MD, et al.
Publicado em: (2024-09-01)

Development and assessment of in vitro tumour models for anti-cancer drug testing
por: Liu, X
Publicado em: (2011)

Three-dimensional spheroid culture of adipose stromal vascular cells for studying adipogenesis in beef cattle
por: Y.N. Ma, et al.
Publicado em: (2018-01-01)

Three-Dimensional Ex Vivo Culture for Drug Responses of Patient-Derived Gastric Cancer Tissue
por: Sian Chen, et al.
Publicado em: (2021-02-01)

Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells.
por: Bianco, R, et al.
Publicado em: (2008)

The Use of Biomaterials in Three-Dimensional Culturing of Cancer Cells
por: Novia Hanasti, et al.
Publicado em: (2023-01-01)

Are anti-vascular endothelial growth factor drugs the panacea for all diabetic retinopathy patients?
por: Jacob Koshy
Publicado em: (2013-01-01)

Advances in tissue engineering of cancer microenvironment-from three-dimensional culture to three-dimensional printing
por: Joana Rita Oliveira Faria Marques, et al.
Publicado em: (2023-06-01)

The anti-angiogenic tyrosine kinase inhibitor Pazopanib kills cancer cells and disrupts endothelial networks in biomimetic three-dimensional renal tumouroids
por: Katerina Stamati, et al.
Publicado em: (2020-05-01)

Anti-vascular endothelial growth factor in ophthalmology
por: Sinha Rajesh, et al.
Publicado em: (2009-01-01)

Vascular endothelial growth factor expression in lung cancer.
por: O'Byrne, K, et al.
Publicado em: (1998)

Implications of Three-Dimensional Cell Culture in Cancer Therapeutic Research
por: Kolluri Poornima, et al.
Publicado em: (2022-05-01)

Application of three-dimensional (3D) bioprinting in anti-cancer therapy
por: Bing-Xuan Wu, et al.
Publicado em: (2023-10-01)

Morphological analysis of human umbilical vein endothelial cells co-cultured with ovarian cancer cells in 3D: An oncogenic angiogenesis assay.
por: Xiao Wan, et al.
Publicado em: (2017-01-01)

Review of three-dimensional spheroid culture models of gynecological cancers for photodynamic therapy research
por: RWK Wu, et al.
Publicado em: (2024-02-01)

Newer anti-vascular endothelial growth factor agents
por: Priya Rasipuram Chandrasekaran
Publicado em: (2020-01-01)

Anti-cancer effects of F16: A novel vascular endothelial growth factor receptor–specific inhibitor
por: Appu Rathinavelu, et al.
Publicado em: (2017-11-01)

The Evolution of Endothelial Regulatory Paradigms in Cancer Biology and Vascular Repair
por: Franses, Joseph W., et al.
Publicado em: (2016)

Vascular endothelial growth factor inhibitors in the treatment of ovarian cancer
por: S. V. Khokhlova
Publicado em: (2014-08-01)

Anti-Vascular Endothelial Growth Factor Agents for Ocular Angiogenesis and Vascular Permeability
por: Toshiaki Kubota, et al.
Publicado em: (2012-01-01)

Effectiveness of treatment of exudative age-related macular degeneration with anti-vascular endothelial growth factor drugs
por: Raquel Coelho de Souza Lima Melo, et al.
Publicado em: (2024-07-01)

The economic implications of the use of anti-vascular endothelial growth factor drugs in age-related macular degeneration
por: Azad Rajvardhan, et al.
Publicado em: (2007-01-01)